Related Experiment Video
Updated: Jan 19, 2026
Noninvasive Electrocardiography in the Perinatal Mouse
Published on: June 12, 2020
Peripartum Cardiomyopathy: A Review
Lindsay C Ballard1, Adrian Cois2, Bory Kea3
1Department of Emergency Medicine, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Rd, Portland, Oregon 97239-3098.
Insights
Peripartum cardiomyopathy (PPCM) is a serious heart condition affecting women during pregnancy or postpartum. Research highlights genetic factors and hormonal imbalances as potential causes, with ongoing efforts to improve diagnosis and management.
Area of Science:
- Cardiology
- Genetics
- Obstetrics
Background:
- Peripartum cardiomyopathy (PPCM) is a significant cause of maternal morbidity and mortality globally.
- Patients with PPCM face a high risk of long-term cardiac complications requiring ongoing medical care.
Purpose of the Study:
- To review recent literature on Peripartum cardiomyopathy (PPCM).
- To provide insights into the etiology, diagnosis, and management of PPCM.
Main Methods:
- Literature review of recent studies on Peripartum cardiomyopathy.
- Analysis of genetic, hormonal, and vascular research related to PPCM.
Main Results:
- Genetic markers such as TTNC1, TTN, and STAT3 show prevalence in PPCM patients.
- Imbalances in angiogenesis, influenced by placental angiogenic factors and genetic mutations, are implicated as a primary etiology.
- Current biomarkers are insufficient to distinguish PPCM from other heart failure types.
Conclusions:
- Women diagnosed with PPCM have increased risks of cesarean sections, hypertensive disorders, and major adverse cardiac events.
- PPCM is associated with lifelong morbidity for affected women.
- Further research is needed to develop specific biomarkers for PPCM.
Purpose Of Review:
Peripartum cardiomyopathy (PPCM) is an important condition with high morbidity and mortality worldwide. Patients with PPCM are at risk of developing life-long cardiac disease, requiring regular management and medical intervention. This article conducts a review of recent literature and gives insight into this disease.
Recent Findings:
There is promising research in the fields of vascular, hormonal and genetics. A number of genetic markers are being analyzed; including TTNC1, TTN and STAT3. Mutations to these genes have been found to be prevalent in PPCM. These combined with the secretion of placental angiogenic factors potentially create imbalance in angiogenesis as the primary etiology.
Summary:
Current biomarkers do not differentiate between PPCM and other variants of heart failure. Women with PPCM are more likely to have a cesarean section, have hypertensive disease, at greater risk of major adverse cardiac events and to have lifelong morbidity.
